UTICA, N.Y. — ConMed Corp. (NASDAQ: CNMD) has appointed Todd Garner as executive VP and CFO, “effective immediately.”
Garner brings over two decades of senior finance and investor-relations experience to ConMed, the Utica–based surgical-device maker said in a news release issued Tuesday.
That experience includes 15 years at Murray Hill, New Jersey–based C. R. Bard, Inc. (Bard), where he most recently served as VP of investor relations.
Prior to that, he was VP, controller (division CFO) of Bard’s medical division; director of the company’s corporate financial reporting; and controller for the company’s Reynosa operations in Mexico.
Prior to joining Bard, he served as controller and acting CFO at Pleasanton, California–based Echopass Corp., which Daly City, California–based Genesys later acquired. Garner, a certified public accountant, also previously served as value planning manager at Clearfield, Utah–based Futura Industries Corp.
ConMed is “very excited to welcome” Garner to its executive team, Curt Hartman, president and CEO of ConMed, said in the firm’s release.
“During his distinguished career, he has made significant contributions to building and transforming finance teams, implementing innovative reporting processes, as well as executing large-scale capital allocation and merger and acquisition strategies. Todd’s deep experience and senior leadership skills will be instrumental in continuing to advance our achievement of the company’s growth and profitability goals,” said Hartman.
ConMed has built an “impressive” executive team and product portfolio, both of which position the company as an “innovative industry leader,” Garner said in the release.
“I am excited about the strategic milestones the Company has achieved to date and am committed to contributing to ConMed reaching its next level of operational and financial success,” Garner added.
ConMed last November announced that Luke Pomilio, who has served as the firm’s executive VP and CFO for the past three years, had announced his intention to retire. Pomilio will remain with ConMed in the role of adviser to CFO and continue with the company through March 1, 2019 in order to “facilitate a smooth transition.”
ConMed, a medical-technology company, provides surgical devices and equipment for minimally invasive procedures. The firm employs about 3,100 people.
Contact Reinhardt at ereinhardt@cnybj.com